| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.75B | 25.93B | 22.68B | 14.25B | 14.08B | 15.55B |
| Gross Profit | 7.87B | 8.63B | 7.86B | 3.71B | 3.95B | 3.30B |
| EBITDA | 2.87B | 4.07B | 4.41B | 294.35M | 813.73M | 516.33M |
| Net Income | 1.44B | 2.26B | 2.42B | -249.47M | 53.27M | -124.48M |
Balance Sheet | ||||||
| Total Assets | 18.40B | 20.40B | 19.95B | 14.86B | 14.45B | 15.13B |
| Cash, Cash Equivalents and Short-Term Investments | 2.36B | 2.07B | 2.96B | 3.18B | 4.09B | 3.39B |
| Total Debt | 819.04M | 1.75B | 3.07B | 5.44B | 4.48B | 5.73B |
| Total Liabilities | 8.92B | 10.30B | 13.07B | 10.17B | 9.67B | 10.22B |
| Stockholders Equity | 9.49B | 10.10B | 6.88B | 4.69B | 4.78B | 4.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -254.63M | 1.89B | -1.71B | 2.10B | -1.61B |
| Operating Cash Flow | 0.00 | 1.18B | 2.34B | -1.49B | 2.30B | -1.13B |
| Investing Cash Flow | 0.00 | -1.56B | -105.31M | -222.11M | -138.95M | -481.36M |
| Financing Cash Flow | 0.00 | -543.06M | -2.48B | 781.24M | -1.42B | 2.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $6.73T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥97.08B | 10.19 | ― | 3.02% | -14.47% | -26.11% | |
70 Outperform | ¥79.33B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
68 Neutral | ¥6.93B | 1.51 | ― | 2.63% | -7.06% | -58.58% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥494.31B | 15.62 | ― | 2.57% | 4.81% | -49.43% | |
47 Neutral | ¥37.61B | 9.09 | 2.26% | ― | -2.53% | -85.61% |
Lecip Holdings reported consolidated net sales of ¥15.46 billion for the nine months ended 31 December 2025, down 1.8% year on year, as operating profit fell 56.0% to ¥790 million and ordinary profit declined 52.1% to ¥952 million. Profit attributable to owners of parent dropped 27.7% to ¥900 million, while earnings per share slid to ¥58.39, reflecting weaker profitability despite broadly stable revenues.
The company’s financial position remained solid, with total assets of ¥20.29 billion and an equity ratio improving to 52.9%, pushing net assets per share up to ¥694.22. For the full year ending March 31, 2026, Lecip forecasts a 7.4% decline in net sales to ¥24.0 billion but expects operating and ordinary profit to rebound by about 69%, and plans a fiscal-year-end dividend of ¥13.50 per share, signaling confidence in earnings recovery and continued shareholder returns despite near-term headwinds.
The most recent analyst rating on (JP:7213) stock is a Hold with a Yen474.00 price target. To see the full list of analyst forecasts on Lecip Holdings Corporation stock, see the JP:7213 Stock Forecast page.